Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 643.82 Mn | 643.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.23% |
| Dec 31, 2025 | 46.93% |
| Sep 30, 2025 | -45.87% |
| Jun 30, 2025 | -16.30% |
| Mar 31, 2025 | -71.73% |
| Sep 30, 2024 | 35.45% |
| Jun 30, 2024 | -21.94% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | -17.50% |
| Sep 30, 2023 | -15.68% |
| Jun 30, 2023 | -62.01% |
| Mar 31, 2023 | -87.32% |
| Dec 31, 2022 | 153.73% |
| Sep 30, 2022 | -47.60% |
| Jun 30, 2022 | -52.04% |
| Dec 31, 2021 | -32.70% |
| Mar 31, 2021 | -3.07% |
| Dec 31, 2020 | -104.36% |
| Sep 30, 2020 | 39.21% |
| Jun 30, 2020 | 21.03% |